Dow's Nearly 125-Point Rally Highlighted By Gains For Shares Of Salesforce, UnitedHealth

Dow Jones
Yesterday

DJ Dow's Nearly 125-Point Rally Highlighted By Gains For Shares Of Salesforce, UnitedHealth

This article was automatically generated by MarketWatch using technology from Automated Insights.

Buoyed by strong returns for shares of Salesforce and UnitedHealth, the Dow Jones Industrial Average is trading up Wednesday morning.

The Dow (Dow Jones Industrial Average) was most recently trading 120 points higher (0.3%), as shares of Salesforce (Salesforce Inc.) and UnitedHealth (UnitedHealth Group Inc.) have contributed to the blue-chip gauge's intraday rally.

Salesforce's shares have risen $3.26 (1.3%) while those of UnitedHealth are up $3.84 (1.3%), combining for an approximately 44-point bump for the Dow.

Also contributing significantly to the gain are Chevron (Chevron Corp.), McDonald's (McDonald's Corp.), and Nike (Nike Inc. Cl B).

A $1 move in any one of the 30 components of the Dow equates to a 6.15-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled August 27, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

August 27, 2025 09:45 ET (13:45 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10